Clinical Trial Update: Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial comparing lopinavir/ritonavir monotherapy to standard highly active antiretroviral therapy in antiretroviral-naive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: HIV Infections, Hepatitis C | Phase 3 | Status: UNKNOWN